Perspective Therapeutics, Inc.
CATX
$1.92
-$0.02-1.03%
AMEX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -79.28M | -63.79M | -59.02M | -58.42M | -46.51M |
| Total Depreciation and Amortization | 3.01M | 1.57M | 1.18M | 871.00K | 714.00K |
| Total Amortization of Deferred Charges | 7.00K | 7.00K | 7.00K | 7.00K | 7.00K |
| Total Other Non-Cash Items | 26.88M | 15.77M | 14.93M | 15.80M | 6.31M |
| Change in Net Operating Assets | 31.80M | 45.74M | 28.73M | 28.40M | 2.56M |
| Cash from Operations | -18.29M | -696.00K | -14.17M | -13.34M | -36.91M |
| Capital Expenditure | -54.41M | -39.89M | -10.40M | -9.94M | -1.07M |
| Sale of Property, Plant, and Equipment | 335.00K | -- | -- | -- | -- |
| Cash Acquisitions | -- | 0.00 | 0.00 | 0.00 | 2.70M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -164.85M | -40.53M | -40.51M | -38.24M | 22.75M |
| Cash from Investing | -218.93M | -80.42M | -50.91M | -48.19M | 24.37M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -48.00K | -48.00K | -53.00K | -65.00K | -68.00K |
| Issuance of Common Stock | 289.08M | 289.44M | 288.82M | 167.26M | 918.00K |
| Repurchase of Common Stock | -287.34M | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 288.06M | 0.00 | 0.00 | 0.00 | -65.00K |
| Cash from Financing | 289.39M | 289.39M | 288.77M | 167.19M | 785.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 52.16M | 208.28M | 223.69M | 105.67M | -11.76M |